The study also revealed a novel mechanism for the anti-tumor activity of berberine through the induction of PTEN gene expression and subsequent suppression of the PI3K/AKT/mTOR signaling pathway, which regulates cells’ proliferation. The gene discussed is MTOR; the disease is neoplasm.